Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III placebo-controlled trial of Dinggui oil soft capsules for abdominal pain in diarrhea-predominant irritable bowel syndrome
CTR20211250Phase 3Completed
- Sponsor
- Chengdu Shangke Pharmaceutical
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Dingguiyou in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Chengdu Shangke Pharmaceutical. Started Aug 2021; status: completed.
02
Drugs
Dingguiyou
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20211250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211250.